Recently, several tumor-specific proteins have been identified as GC biomarkers in the clinical diagnosis, such as carcinoembryonic antigen (CEA), cancer antigen 72-4 (CA72-4) and cancer antigen 19-9 (CA19-9)9–11. The gene discussed is CEACAM5; the disease is neoplasm.